{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/25/3350465/0/en/incannex-announces-first-patient-dosed-in-dreamzz-phase-2-study-of-ihl-42x.html", "message": "News view counter 900883 successfully enlarged"}